The independent source for health policy research, polling, and news.
16,101 - 16,120 of 112,606 Results
As worries emerge about the FDA's stance on drug review processes, the Biden administration faces pressure to finally nominate a permanent commissioner to lead the agency, which has a critical role in ending the pandemic.
New guidelines released by the U.S. Preventive Services Task Force recommend that all Americans between 50 and 80 who smoke or quit smoking in the past 15 years should get annual screenings. Insurers can't charge a copay to people who meet the criteria.
The vial that was used on America’s first coronavirus vaccine recipient is now a historic artifact, property of the Smithsonian’s National Museum of American History. Meanwhile, studies say it's safe to use a face mask during intense exercise, and other reports link steroid use to bodybuilder's testicular damage.
The House is expected to vote today on the $1.9 trillion legislation that is packed with measures that will reach far beyond the $1,400 relief checks.
That's still around 58,000 new cases a day. Dr. Anthony Fauci worries that new coronavirus infections on the U.S. may “plateau again at an unacceptably high level.” Hospitalizations are also down.
The union, one of the most powerful in the country, took a hard line on vaccinations as a prerequisite for reopening the nation's second-largest school district. No specific date was given for reopening.
In Pasadena, California, ineligible sign ups forced a vaccination clinic to close. Meanwhile, two mass sites in Utah are running below capacity. Vaccine rollout news from other states is in the news too.
Some states like New York and Florida are now targeting younger age groups and others are including a broader range of preconditions and employment roles in their pandemic vaccine priority lists. But a new poll suggests 25% of people will still refuse.
Anyone 16 and older -- the age cutoff for FDA approval of the vaccine -- can now get a shot in Alaska. Gov. Mike Dunleavy called the stage a "game changer."
Today's early morning highlights from the major news organizations.
The WTO is considering a pharmaceutical patent rights waiver to boost coronavirus efforts in poorer nations, but drugmakers want President Joe Biden to say no. Meanwhile Russia's vaccine will be made in Switzerland, and the Pope defends his Iraq visit.
Opinion writers weigh in on vaccinations and the global pandemic.
Editorial pages tackle mental health issues, pregnancy and asbestos exposure.
A group of tourists sue Disney, alleging they caught coronavirus aboard a cruise ship in early 2020. Other news includes phobia-inducing worries about injection imagery and undocumented immigrants battling the pandemic with no safety net.
At a pandemic turning point, New York City and L.A. authorities plan to reopen some schools. Elsewhere in the U.S., states battle with nursing home covid controversies, and pharmacies get the OK to administer birth control pills.
A trial of Tecentriq, a Roche drug that was granted accelerated approval in 2016 to treat bladder cancer, has shown that the drug failed to improve overall survival, Stat reports. Last month, AstraZeneca experienced a similar problem with Imfinzi.
If approved in the House -- which it's expected to be, as progressive Democrats signal their support -- President Joe Biden pledges to sign the legislation as soon as it reaches his desk.
As health professionals and disease experts plead with Americans to avoid the vacation trap, some schools are canceling or shortening their breaks to discourage students from heading to party destinations.
Every state has now prioritized K-12 educators to receive the coronavirus vaccine. News outlets also report on hesitant groups.
The higher the patient's body mass index, the higher the risk, the study of nearly 150,000 adults found. In other covid news: Many long-haulers were asymptomatic during their initial infection, research shows.
© 2026 KFF